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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A225accounting for the systematic offset between bothmethods. Goniometry,
in contrast, was a poor predictor formedial and lateral cartilage thickness
loss. If the FTA offset is not adjusted for, the new method of measuring
alignment from ﬁxed ﬂexion radiographs is shifted in the varus direction,
and has limited ability to predict future LFTC cartilage loss.
Figure 1. Adjusted odds ratios and 95% conﬁdence intervals for measures
of alignment predicting MFTC/LFTC progressors and non-progressors from
baseline to 2-year follow-up.
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CLINICAL SIGNIFICANCE OF A KNEE EFFUSION DETECTED ON
PHYSICAL EXAMINATION IN A PATIENT WITH KNEE OA
J.L. Jaremko, D. McDougall, B. Smith, R.G. Lambert, W.P. Maksymowych.
Univ. of Alberta, Edmonton, AB, Canada
Purpose: With recent focus on the potentially treatable inﬂammatory
component of osteoarthritis (OA), there has been increased interest in
the detection and implications of a joint effusion as a marker of
inﬂammation. Effusions can be detected clinically, primarily via tap and
bulge signs on physical examination. However, there has been sur-
prisingly little objective evaluation of these clinical signs, perhaps
because presence of an effusion at imaging is also somewhat subjective.
Using clinical and imaging data from the Osteoarthritis Initiative, we
sought to determine (1) sensitivity and speciﬁcity of the tap and bulge
signs for the presence of a joint effusion on MRI as measured by two
semi-quantitative scoring systems, and (2) the clinical implication of an
effusion detected on physical examination in terms of pain and dis-
ability at presentation and the rate of use of intra-articular steroid
injection over the next year.
Methods: Patients: This retrospective cohort study includes knees from
40 subjects from the Osteoarthritis Initiative (OAI) that went on to have
a knee steroid injectionwithin 1 year of baseline evaluation, and 40 that
did not, matched by age, sex, and Kellgren-Lawrence (K-L) grade of
radiographic OA. Age averaged 62.3 years (range: 45-78), K-L grade
2.8±1.0 (mean±standard deviation), 78% were women, and body mass
index (BMI) averaged 30.3±4.6.
Clinical data: In addition to demographics above, the variables extrac-
ted from OAI included at baseline visit (year 0) the tap and bulge signs
for effusion (positive/negative), Western Ontario & McMaster
(WOMAC) pain and status scores.
MRI evaluation for effusion: After initial consensus training, two mus-
culoskeletal radiologists separately scored each knee on two semi-
quantitative effusion scores: MOAKS, which grades the whole joint by a
single number from 0 (no effusion) to 3 (large effusion), and KIMRISS,
where the depth of joint ﬂuid is measured and graded at four sites on
axial and sagittal MRI (medial, lateral and superior suprapatellar
recesses and Baker cyst), then summed for a score from 0-12.
Statistics: The tap sign was highly insensitive (only four positive cases)
and not examined further. We compared the prevalence and size of
effusions at MRI in patients with positive and negative bulge sign using
nonparametric Mann-Whitney U test. We computed sensitivity/specif-
icity of the bulge sign for detecting an effusion visible at MRI at various
MOAKS and KIMRISS thresholds. In bulgeþ and bulge- cohorts we
compared WOMAC pain and status scores at baseline and the rates of
steroid injections in that knee after 1 year, all by Mann-Whitney U test.
Results: Effusion prevalence was high at MRI (MOAKS >¼1 in 70%,
KIMRISS >¼4 in 72%). The bulge-positive knees (n¼18) had signiﬁcantly
larger effusions than bulge-negative knees (n¼62), whether by MOAKS(1.3±0.1 vs. 0.8±0.1, p¼0.01) or KIMRISS (5.6±0.3 vs. 4.2±0.3, p¼0.02;
Figure 1). In the full data set, sensitivity for an effusion was optimal at
thresholds of MOAKS 1 or KIMRISS 4, at 0.3-0.32, with speciﬁcity 0.83-
1.0, and there was no signiﬁcant difference in WOMAC pain or status
scores between bulgeþ/bulge-¼ knees. However, when analysis was
limited to non-obese patients (BMI<30, n¼36), sensitivity improved
slightly, to 0.38-0.39, and the bulgeþ knees (n¼9) had substantially
higher average WOMAC scores than others (pain 5.1 vs 2.1, p¼0.003,
status 23.8 vs 10.0, p¼0.004). Within the year after initial observation,
14/18 (77%) of the bulgeþ group had received steroid injections in that
knee, vs. 26/62 (42%) of the bulge- group (p¼0.007).
Conclusions: Signs of knee effusion on physical examination are
insensitive, especially in obese patients, and the tap sign is so rarely
positive as to be of little value. When an effusion is detected by bulge
sign in a patient with established knee OA, it is associated with a larger
knee effusion at MRI, signiﬁcantly greater current pain and disability,
and a signiﬁcantly higher rate of steroid injections into that knee in the
next year than if no effusion is detected clinically. These associations
support the notion that a joint effusion reﬂects active synovitis, and
encourage careful clinical examination for knee effusions.
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PATELLO-FEMORAL OSTEOARTHRITIS AT BASELINE IS PREDICTIVE
FOR TIBIO-FEMORAL OSTEOARTHRITIS FIVE YEARS LATER AND
VICE VERSA
D. Schiphof, E.H. Oei, E.J. Waarsing, S.M. Bierma-Zeinstra. Erasmus MC,
Rotterdam, Netherlands
Purpose: The awareness of the importance of patellofemoral osteo-
arthritis (PFOA) is increasing in recent years. Suggested is that PFOA is
the precursor of tibiofemoral OA. Is PFOA at baseline predictive for TFOA
ﬁve years later? The other way aroundmight also be possible, so is TFOA
at baseline predictive for PFOA ﬁve years later.
Methods: Of a random subsample (n¼337) of the 891 females (aged 45-
60) from the nested cohort of the Rotterdam Study, baseline and 5-years
follow-up MRIs of both knees were assessed for knee OA with the MRI
Osteoarthritis Knee Scoring (MOAKS). Based on these scored features
we applied the proposed MRI deﬁnition. We distinguished the
PFOAMRI-deﬁnition from the TFOAMRI-deﬁnition. X-rays of both knees
were scored with Kellgren and Lawrence classiﬁcation criteria (K&L).
Binomial logistic generalized estimated equations were used to deter-
mine the predictive value of PFOAMRI for TFOAMRI at follow-up. For
this analysis we excluded the knees with TFOA at baseline. We adjusted
the analysis for age and BMI and for K&L-score at X-ray of the TF- joint.
In addition, we did the same analysis to test if TFOA in knee without
PFOA at baseline was predictive for PFOA at 5 year follow-up.
Results: Figure 1 shows the distribution and shift during follow-up of
the knees deﬁned with isolated PFOAMRI, isolated TFOAMRI, combined
PF&TFOAMRI and knees without OA of the ﬁrst 337 women of whom
MRIs are scored. At baseline mean age is 54.9 years (sd¼3.9) and mean
BMI is 26.9 kg/m2 (sd¼4.3). Mean follow-up time is 5.1 years (sd¼0.4).
Figure 1. Spatial change of bone area (top) and cartilage (bottom), dis-
played on the mean bone shapes. Blue represents decrease in measure,
red represents increase (see scale). Regions used in this study are shown
on the bone area ﬁgures at the top, and the boundary of the medial and
lateral femur regions is shown as a dotted line. This line represents the
anterior edge of the menisci in the mean shape model.
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analysis with just one knee). Of these 595 knees 30 knees have PFOA at
baseline; 56 knees (9.7%) have PFOAMRI at follow up and 46 knees
(7.9%) have TFOAMRI at follow up. PFOA was associated with TFOA at
follow-up with an odds ratio (OR) of 7.3 (3.2-17.0; p<0.001) inde-
pendent of the K&L-score (OR¼3.0 (1.6-5.8); p¼0.001). Pretest pre-
dictive value was 7.7% (46/595); posttest predictive value is 40% (12/30).
In the knees without PF OA (n¼607) at baseline 42 knees were deﬁned
with TFOA at baseline, 73 were deﬁned with TFOA at follow-up (3 knees
had a TKR) and 37 knees were deﬁned with PFOA at follow-up. TFOA at
baseline was associated with PFOA at follow-up (OR¼6.5 (2.5-17.0)
p<0.001) independent of age, BMI and K&L score. K&L score was not
associated with PFOA at follow-up at all (OR¼0.92 (0.4-2.3); p¼0.85).
Pretest predictive value is 6.3% (38/607) and posttest predictive value is
28.6% (12/42).
Conclusions: Structural PFOAMRI at baseline is predictive for structural
TFOAMRI at follow-up independent of K&L score. TFOAMRI at baseline
is predictive for PFOAMRI at follow-up independent of K&L score. These
results will be validated in the second subsample of the cohort.
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CHANGE IN BONE AREA DOES NOT CORRELATE WITH CARTILAGE
LOSS OVER 12 MONTHS IN INDIVIDUALS WITH KNEE OA: DATA
FROM THE OSTEOARTHRITIS INITIATIVE
M.A. Bowes y, C.B. Wolstenholme y, G.R. Vincent y, P.G. Conaghan z.
y Imorphics Ltd, Manchester, United Kingdom; z Leeds Inst. of Rheumatic
and Musculoskeletal Med., University of Leeds, United KingdomPurpose: The involvement of subchondral bone in knee osteoarthritis
(OA) is well known, and it has been proposed that changes of bone
shape may be a marker of disease progression, and contribute to an
understanding of OA pathogenesis.
It is not known how this new measure relates to the more established
measure of cartilage thickness. This study used statistical shape mod-
elling to study whether bone changes correlate with cartilage change
within anatomical regions, and whether the same individuals change
more than measurement noise using the two measures over a one-year
period, a typical period for a clinical trial.
Methods: A convenience cohort of 88 subjects with medial knee OAwas
identiﬁed from the NIH-OAI dataset. Subjects had K-L scores of 2 or 3;
medial JSN > lateral JSN, medial osteophytes and 1 of varus mal-
alignment; 43 were female.
Baseline and 12-month DESS images were manually segmented for
articular cartilage. Segmenters were blinded to time point but not to
subject, using EndPoint software (Imorphics, UK). Bone surfaces were
identiﬁed by automated segmentation using active appearance models
(AAMs). This methodology provides a dense set of anatomically corre-
sponded points on each bone surface, allowing mapping of bone and
cartilage in a consistent measurement frame.
Average thickness (ThCtAB) of the cartilage for each major compart-
ment of the femur, tibia and patella was calculated. Bone area (tAB) was
measured using anatomical areas identiﬁed on the triangulated mean
bone shape.
Population maps were prepared to display the mean change in bone
and cartilage on the bone surfaces for visual comparison (Figure 1). For
each anatomical region, individuals with change greater than the
smallest detectable difference (SDD) were identiﬁed. SDD was calcu-
lated using a set of 29 individuals with DESS images, taken at one week
apart. The number of individuals who showed change greater than SDD
for both measures were calculated. Correlation between bone and
cartilage change was measured using Pearson's correlation coefﬁcient.
Results: Bone area and cartilage thickness both showed signiﬁcant
change in one or more anatomical regions (Table 1). Both types of
measure showed similar sensitivity, as judged by the standardised
response mean (SRM) The pattern of change for the 2 measures was
somewhat different. Change in cartilage thickness was typically neg-
ative, representing cartilage loss, and was located in the articulating
surfaces of the femorotibial joint, and the lateral facet of the patella
(Figure 1). Bone change was typically positive, representing increased
bone area. Change was most evident around the edge of all cartilage
plates, but was also present, at a lower rate of change, in the articulating
surfaces of femur and tibia bones (the areas where cartilage showed
change). There was no obvious strong pattern of spatial similarity
between the 2 measures, except for this change in the articulating
